MYH13: Difference between revisions
Appearance
Content deleted Content added
m →Further reading: cleanup ä --> ä, ü --> ü , Ã¥ --> ã, ö --> ö, etc..., replaced: ö → ö using AWB |
No edit summary |
||
(8 intermediate revisions by 5 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Protein-coding gene in the species Homo sapiens}} |
|||
{{PBB|geneid=8735}} |
|||
{{Infobox_gene}} |
|||
⚫ | '''Myosin-13''' also known as '''myosin, heavy chain 13''' is a [[protein]] which in humans is encoded by the ''MYH13'' [[gene]].<ref name="pmid9806854">{{cite journal |vauthors=Winters LM, Briggs MM, Schachat F | title = The human extraocular muscle myosin heavy chain gene (MYH13) maps to the cluster of fast and developmental myosin genes on chromosome 17 | journal = Genomics | volume = 54 | issue = 1 | pages = 188–9 |date=November 1998 | pmid = 9806854 | doi = 10.1006/geno.1998.5558 }}</ref> <ref name="pmid10388558">{{cite journal |vauthors=Weiss A, Schiaffino S, Leinwand LA | title = Comparative sequence analysis of the complete human sarcomeric myosin heavy chain family: implications for functional diversity | journal = J. Mol. Biol. | volume = 290 | issue = 1 | pages = 61–75 |date=July 1999 | pmid = 10388558 | doi = 10.1006/jmbi.1999.2865 }}</ref> |
||
⚫ | '''Myosin-13''' also known as '''myosin, heavy chain 13''' is a [[protein]] which in humans is encoded by the ''MYH13'' [[gene]].<ref name="pmid9806854">{{cite journal | |
||
== Function == |
== Function == |
||
MYH13 is a [[myosin]] whose expression is restricted primarily to the extrinsic eye muscles which are specialized for function in eye movement.<ref name=" |
MYH13 is a [[myosin]] whose expression is restricted primarily to the extrinsic eye muscles which are specialized for function in eye movement.<ref name="pmid9806854">{{cite journal |vauthors=Winters LM, Briggs MM, Schachat F | title = The human extraocular muscle myosin heavy chain gene (MYH13) maps to the cluster of fast and developmental myosin genes on chromosome 17 | journal = Genomics | volume = 54 | issue = 1 | pages = 188–9 |date=November 1998 | pmid = 9806854 | doi = 10.1006/geno.1998.5558 }}</ref> |
||
== References == |
== References == |
||
Line 13: | Line 15: | ||
{{refbegin | 2}} |
{{refbegin | 2}} |
||
*{{cite journal | |
*{{cite journal |vauthors=Weiss A, McDonough D, Wertman B, etal |title=Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=96 |issue= 6 |pages= 2958–63 |year= 1999 |pmid= 10077619 |doi= 10.1073/pnas.96.6.2958|pmc=15877 |bibcode=1999PNAS...96.2958W |doi-access=free }} |
||
*{{cite journal | |
*{{cite journal |vauthors=Schachat F, Briggs MM |title=Phylogenetic implications of the superfast myosin in extraocular muscles. |journal=J. Exp. Biol. |volume=205 |issue= Pt 15 |pages= 2189–201 |year= 2002 |doi=10.1242/jeb.205.15.2189 |pmid= 12110653 }} |
||
*{{cite journal | |
*{{cite journal |vauthors=Trynka G, Zhernakova A, Romanos J, etal |title=Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. |journal=Gut |volume=58 |issue= 8 |pages= 1078–83 |year= 2009 |pmid= 19240061 |doi= 10.1136/gut.2008.169052 |s2cid=17111427 |url=https://research.vumc.nl/en/publications/9f0b4115-baf6-4bc6-ab6b-4fd7f23f0f0a }} |
||
*{{cite journal | |
*{{cite journal |vauthors=Lehner B, Sanderson CM |title=A protein interaction framework for human mRNA degradation. |journal=Genome Res. |volume=14 |issue= 7 |pages= 1315–23 |year= 2004 |pmid= 15231747 |doi= 10.1101/gr.2122004 |pmc=442147 }} |
||
*{{cite journal | |
*{{cite journal |vauthors=Schjeide BM, McQueen MB, Mullin K, etal |title=Assessment of Alzheimer's disease case-control associations using family-based methods. |journal=Neurogenetics |volume=10 |issue= 1 |pages= 19–25 |year= 2009 |pmid= 18830724 |doi= 10.1007/s10048-008-0151-3 |pmc=2841132 }} |
||
*{{cite journal | |
*{{cite journal |vauthors=Shoeman RL, Sachse C, Höner B, etal |title=Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin. |journal=Am. J. Pathol. |volume=142 |issue= 1 |pages= 221–30 |year= 1993 |pmid= 8424456 |pmc=1886840 }} |
||
{{refend}} |
{{refend}} |
||
Latest revision as of 15:58, 1 February 2024
MYH13 | |||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Identifiers | |||||||||||||||||||||||||||||||||||||||||||||||||||
Aliases | MYH13, MyHC-IIL, MyHC-eo, myosin, heavy chain 13, skeletal muscle, myosin heavy chain 13 | ||||||||||||||||||||||||||||||||||||||||||||||||||
External IDs | OMIM: 603487; MGI: 1339967; HomoloGene: 55780; GeneCards: MYH13; OMA:MYH13 - orthologs | ||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Wikidata | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
Myosin-13 also known as myosin, heavy chain 13 is a protein which in humans is encoded by the MYH13 gene.[5] [6]
Function
[edit]MYH13 is a myosin whose expression is restricted primarily to the extrinsic eye muscles which are specialized for function in eye movement.[5]
References
[edit]- ^ a b c GRCh38: Ensembl release 89: ENSG00000006788 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000060180 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ a b Winters LM, Briggs MM, Schachat F (November 1998). "The human extraocular muscle myosin heavy chain gene (MYH13) maps to the cluster of fast and developmental myosin genes on chromosome 17". Genomics. 54 (1): 188–9. doi:10.1006/geno.1998.5558. PMID 9806854.
- ^ Weiss A, Schiaffino S, Leinwand LA (July 1999). "Comparative sequence analysis of the complete human sarcomeric myosin heavy chain family: implications for functional diversity". J. Mol. Biol. 290 (1): 61–75. doi:10.1006/jmbi.1999.2865. PMID 10388558.
Further reading
[edit]- Weiss A, McDonough D, Wertman B, et al. (1999). "Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved". Proc. Natl. Acad. Sci. U.S.A. 96 (6): 2958–63. Bibcode:1999PNAS...96.2958W. doi:10.1073/pnas.96.6.2958. PMC 15877. PMID 10077619.
- Schachat F, Briggs MM (2002). "Phylogenetic implications of the superfast myosin in extraocular muscles". J. Exp. Biol. 205 (Pt 15): 2189–201. doi:10.1242/jeb.205.15.2189. PMID 12110653.
- Trynka G, Zhernakova A, Romanos J, et al. (2009). "Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling". Gut. 58 (8): 1078–83. doi:10.1136/gut.2008.169052. PMID 19240061. S2CID 17111427.
- Lehner B, Sanderson CM (2004). "A protein interaction framework for human mRNA degradation". Genome Res. 14 (7): 1315–23. doi:10.1101/gr.2122004. PMC 442147. PMID 15231747.
- Schjeide BM, McQueen MB, Mullin K, et al. (2009). "Assessment of Alzheimer's disease case-control associations using family-based methods". Neurogenetics. 10 (1): 19–25. doi:10.1007/s10048-008-0151-3. PMC 2841132. PMID 18830724.
- Shoeman RL, Sachse C, Höner B, et al. (1993). "Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin". Am. J. Pathol. 142 (1): 221–30. PMC 1886840. PMID 8424456.